Skip to content

Impact of yoga on quality of life in blood cell transplant patients

A randomized controlled trial to assess the impact of yoga on health-related quality of life in hematopoietic cell transplant recipients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/11/047276
Enrollment
96
Registered
2022-11-14
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D50-D89- Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

Interventions

Intervention1: Yoga practice: Sookshma Vyayama- Gentle stretches Sectional followed by Yogic Breathing Sitali/ sheetkari/sadanta Nadishodana Bramari pranayama Quick relaxation technique Once daily f

Sponsors

Central Council for Research in Yoga and Naturopathy
Lead Sponsor
Central Council for Research in Yoga and Naturopathy
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: (1) all adults (Age >= 18 years at the time of transplant), (2) all transplant recipients (autologous/ allogeneic) (3) those willing to adhere to Yoga Intervention for the period of the study

Exclusion criteria

Exclusion criteria: (1)Those not willing to consent (2)Those without access to a smartphone (3)Regular practitioner of yoga, meditation or other mind-body practice (definition: taking classes or practising at least weekly for at least 2 of the past 6 months).

Design outcomes

Primary

MeasureTime frame
Change in BMT subscale scores of the FACT-BMT questionnaireTimepoint: Baseline and 3 months

Secondary

MeasureTime frame
Adherence to the yoga practiceTimepoint: 3 months;Change in diurnal salivary cortisol slopesTimepoint: 3 months;Change in Heart rate variability parametersTimepoint: 3 months;Change in HR-QoL at 6/12-months after HCTTimepoint: 6 and 12 months;Change in HR-QoL scores as assessed by FACT-BMT (version 4) questionnaire and Cancer and Treatment Distress as measured by CTXD toolTimepoint: 3 months;Change in Telomere lengthTimepoint: 3 months;Incidence of acute graft versus host diseaseTimepoint: 3 months

Countries

India

Contacts

Public ContactDEEPESH LAD

PGIMER

Lad.deepesh@pgimer.edu.in

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026